Set StockTrendNews.com as your Homepage! - Click Here Home     About Us     Subscribe     Contact
 
StockTrendNews (STN) Exclusive: AEterna Zentaris, Incorporated
Enter Symbol or Keywords
x
Two Year High in EBITDA for Aeterna Zentaris   Stock Quote: (NGM:AEZS)
11/18/2009  
0.82 0.00 0.00% 0
Two Year High in EBITDA for Aeterna Zentaris  
Last Price Change % Chg Volume
New York, NY, November 18, 2009-Ebitda News reports that negative EBITDA for Aeterna Zentaris Inc. (NASDAQ:AEZS) for its quarter ended September 30, 2009 was $(6,275,000), a 43% improvement over the y ... read full story  
Website Address: www.aezsinc.com
Industry: Bio-Pharma & Therapeutics
Most Recent STN Exclusives
x
02/09/2010
Cash Flow from Operations Improves 82% for News Corp.
02/09/2010
Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months
02/09/2010
Free Cash Flow for News Corp. Reaches Two Year High
02/09/2010
Cash Flow from Operations Turns Positive for Siemens' First Quarter
02/09/2010
StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI
02/08/2010
Second Quarter EBITDA Turns Positive for Harris
02/08/2010
Twelve Year High in EBITDA for Amazon.com
02/08/2010
Cash Flow from Operations for McCormick Reaches Fifteen Year High
02/08/2010
EBITDA for BMC Software Reaches Thirteen Year High
02/08/2010
EBITDA for CA Reaches Nine Year High
Interactive Chart: AEZS
x
More STN Exclusives for: AEZS
x
11/18/2009
Two Year High in EBITDA for Aeterna Zentaris
11/16/2009
Aeterna Zentaris Experiencing Revenue Downtrend While its Industry is in an Uptrend
11/16/2009
Aeterna Zentaris' OPS Ranking of "3" Reiterated by StockDiagnostics.com
... more AEZS exclusives
Other News Sources: AEZS
x
02/03/2010
AEterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-0401) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer
01/29/2010
AEterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia
01/29/2010
Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia
... more AEZS news from other sources
Daily Market Updates
x
02/09/2010
Markets Close Day After Strong Rally as Concerns Ease re Greece
Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story

30 Day Free Trial - MarketWatch Retirement Weekly

Free 30 Day Trial -MarketWatch Hulbert Interactive

Visit Tradesight



Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com

 
 
 
x


 
x
     
 
©2010 StockTrendNews.com
Disclaimer Terms of Sales Privacy About Us